To: Anyone that purchased or otherwise acquired shares of TG Therapeutics, Inc. (“TGTX”) (TGTX) between September 15, 2014 and October 12, 2016. You are hereby notified that a securities class action lawsuit was filed in the U.S. District Court for the Southern District of New York to recover losses suffered by TGTX investors.
The case, Lyon v. TG Therapeutics, Inc. et al, No. 1:17-cv-00112 was filed on January 6, 2017, and is available for review here:
To get more information go to: http://www.zlk.com/pslra/tg-therapeuticsor contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
Take Action: If you suffered a loss in TGTX you have until March 7, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky LLP encourages anyone with information regarding TGTX’s conduct to contact us, including whistleblowers, former employees, shareholders and others.
Levi & Korsinsky LLP is a national securities firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise representing investors in securities lawsuits, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes. We welcome the opportunity to discuss your particular case. All communications will be treated confidentially.
